Article
Omega-3 fatty acid-rich fish oil supplementation prevents rosiglitazone-induced osteopenia in insulin resistant c57bl/6 mice and in vitro studies.
2020-12-29
Abstract excerpt
Rosiglitazone is an effective insulin-sensitizer, however associated with bone loss mainly due to increased bone resorption and bone marrow adiposity. We investigated the effect of the co-administration of fish oil on rosiglitazone-induced bone loss in C57BL/6 mice and the mechanisms underlying potential preventive effect. Mice fed iso-caloric diet supplemented with fish oil exhibited significantly higher levels o...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a04b1a5c-7a76-5c36-92c2-319d149ac0e3
- DOI
- 10.21203/rs.3.rs-126494/v1
